UPF-1035
UPF-1035 is a selective PARP-2 inhibitor with an IC50 value of 0.15 μM. UPF-1035 increases CA1 pyramidal cell loss in hippocampal and has neuroprotective activity[1].
Product Specifications
CAS Number
[370872-09-6]
UNSPSC
12352005
Target
PARP
Type
Reference compound
Related Pathways
Cell Cycle/DNA Damage; Epigenetics
Field of Research
Neurological Disease
Assay Protocol
https://www.medchemexpress.com/upf-1035.html
Smiles
O=C1C2=CC=CC(OC(C3=CC=CC=C3)=O)=C2C=CN1
Molecular Formula
C16H11NO3
Molecular Weight
265.26
References & Citations
[1]F Moroni , et al. Selective PARP-2 inhibitors increase apoptosis in hippocampal slices but protect cortical cells in models of post-ischaemic brain damage. Br J Pharmacol. 2009 Jul;157 (5) :854-62.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
PARP1; PARP2
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS6211734-01 0.1 mL
GNPNAT1 (GNA1, Glucosamine 6-phosphate N-acetyltransferase, Phosphoglucosamine Acetylase, Phosphoglucosamine Transacetylase, FLJ10607, GNPNAT) (MaxLight 550)
Ask
View Details 
MBS6211734-02 5x 0.1 mL
GNPNAT1 (GNA1, Glucosamine 6-phosphate N-acetyltransferase, Phosphoglucosamine Acetylase, Phosphoglucosamine Transacetylase, FLJ10607, GNPNAT) (MaxLight 550)
Ask
View Details MBS6203024-01 0.1 mL
RNPEP (APB, Aminopeptidase B, Arginine Aminopeptidase, Arginyl Aminopeptidase) (MaxLight 490)
Ask
View Details